ACCOLADE INC (ACCD) Stock Price, Forecast & Analysis
USA - NASDAQ:ACCD - US00437E1029 - Common Stock
ACCD Key Statistics, Chart & Performance
The current stock price of ACCD is 7.02 USD. In the past month the price increased by 0.86%. In the past year, price decreased by -14.91%.
ACCD Latest News, Press Relases and Analysis
ACCD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.2 | 97.27B | ||
| CI | THE CIGNA GROUP | 9.63 | 73.02B | ||
| LH | LABCORP HOLDINGS INC | 16.52 | 21.72B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.2 | 20.95B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 106.61 | 19.26B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.47B | ||
| DVA | DAVITA INC | 12.54 | 8.28B | ||
| HIMS | HIMS & HERS HEALTH INC | 65.41 | 7.98B | ||
| CHE | CHEMED CORP | 19.72 | 6.32B | ||
| RDNT | RADNET INC | 213.07 | 6.23B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 31.79 | 5.74B | ||
| OPCH | OPTION CARE HEALTH INC | 18.94 | 4.58B |
Related stock screener links
About ACCD
Company Profile
Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 2,400 full-time employees. The company went IPO on 2020-07-02. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. The company also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
Company Info
ACCOLADE INC
660 W. Germantown Pike Suite 500
Plymouth Meeting PENNSYLVANIA 98101 US
CEO: Rajeev Singh
Employees: 2400
Phone: 16108342989
ACCOLADE INC / ACCD FAQ
What does ACCD do?
Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 2,400 full-time employees. The company went IPO on 2020-07-02. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. The company also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
What is the stock price of ACCOLADE INC today?
The current stock price of ACCD is 7.02 USD. The price decreased by -0.14% in the last trading session.
Does ACCD stock pay dividends?
ACCD does not pay a dividend.
What is the ChartMill technical and fundamental rating of ACCD stock?
ACCD has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Should I buy ACCD stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ACCD.
What is ACCOLADE INC worth?
ACCOLADE INC (ACCD) has a market capitalization of 575.57M USD. This makes ACCD a Small Cap stock.
ACCD Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ACCD. When comparing the yearly performance of all stocks, ACCD turns out to be only a medium performer in the overall market: it outperformed 44.41% of all stocks.
ACCD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ACCD. While ACCD seems to be doing ok healthwise, there are quite some concerns on its profitability.
ACCD Financial Highlights
Over the last trailing twelve months ACCD reported a non-GAAP Earnings per Share(EPS) of -1.06. The EPS increased by 35.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.85% | ||
| ROE | -57.6% | ||
| Debt/Equity | 0.67 |
ACCD Forecast & Estimates
16 analysts have analysed ACCD and the average price target is 6.83 USD. This implies a price decrease of -2.7% is expected in the next year compared to the current price of 7.02.
For the next year, analysts expect an EPS growth of -8.14% and a revenue growth 13.05% for ACCD